This correlation between MIP-C and SARS-CoV-2 infection was supported by the finding that the majority of the anti-MDA5-positive DM cases had either COVID-19 or, later, vaccination prior to development of DM. This evidence concerns the gene IFIH1 and dermatomyositis.